Published in Prog Neuropsychopharmacol Biol Psychiatry on January 01, 1991
Characterization of a multicomponent receptor for GDNF. Nature (1996) 2.92
Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science (1998) 2.83
Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science (1989) 2.46
Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. J Neurosci (1986) 2.33
Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons. Neuron (1995) 2.19
Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature (1995) 1.79
NGF-mediated increase of choline acetyltransferase (ChAT) in the neonatal rat forebrain: evidence for a physiological role of NGF in the brain? Brain Res (1983) 1.77
Regulated release and polarized localization of brain-derived neurotrophic factor in hippocampal neurons. Mol Cell Neurosci (1996) 1.59
Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats. Hypertension (1990) 1.58
Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3. Proc Natl Acad Sci U S A (1991) 1.52
K-252 compounds: modulators of neurotrophin signal transduction. J Neurochem (1992) 1.49
Effects of chronic therapy with cilazapril, a new angiotensin-converting enzyme inhibitor, on regional blood flows in conscious spontaneously hypertensive rats. J Cardiovasc Pharmacol (1987) 1.40
Treatment approaches for congenital pseudarthrosis of tibia: results of the EPOS multicenter study. European Paediatric Orthopaedic Society (EPOS). J Pediatr Orthop B (2000) 1.38
The influence of heregulins on human Schwann cell proliferation. J Neurosci (1995) 1.34
Precursor control of neurotransmitter synthesis. Pharmacol Rev (1980) 1.34
Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization. Brain Res (1980) 1.27
Regulated neurotrophin receptor responsiveness during neuronal migrationand early differentiation. J Neurosci (1994) 1.23
Nerve growth factor increases choline acetyltransferase but not survival or fiber outgrowth of cultured fetal septal cholinergic neurons. Neuroscience (1985) 1.21
Synovial sarcomas usually metastasize after >5 years: a multicenter retrospective analysis with minimum follow-up of 10 years for survivors. Ann Oncol (2010) 1.19
Chronic intraventricular injections of nerve growth factor elevate hippocampal choline acetyltransferase activity in adult rats with partial septo-hippocampal lesions. Brain Res (1984) 1.16
Discoid lateral meniscus in children. Long-term follow-up after total meniscectomy. J Bone Joint Surg Am (1998) 1.16
Cloning of AL-1, a ligand for an Eph-related tyrosine kinase receptor involved in axon bundle formation. Neuron (1995) 1.15
Reconstruction with non-vascularised fibular grafts after resection of bone tumours. J Bone Joint Surg Br (2007) 1.12
Aromatic L-amino acid decarboxylase in rat corpus striatum: implications for action of L-dopa in parkinsonism. Neurology (1981) 1.11
Development of septal cholinergic neurons in culture: plating density and glial cells modulate effects of NGF on survival, fiber growth, and expression of transmitter-specific enzymes. J Neurosci (1988) 1.10
Nonaminergic striatal neurons convert exogenous L-dopa to dopamine in parkinsonism. Ann Neurol (1980) 1.05
Cilazapril prevents hypertension in spontaneously hypertensive rats. J Cardiovasc Pharmacol (1986) 1.05
Brain-derived neurotrophic factor administration protects basal forebrain cholinergic but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brain. J Neurosci (1992) 1.04
Endothelial dysfunction and subendothelial monocyte macrophages in hypertension. Effect of angiotensin converting enzyme inhibition. Hypertension (1991) 1.04
Systemic interleukin-1 beta decreases brain-derived neurotrophic factor messenger RNA expression in the rat hippocampal formation. Neuroscience (1993) 1.01
Is Alzheimer disease caused by lack of nerve growth factor? Ann Neurol (1983) 1.00
BDNF and NGF treatment in lesioned rats: effects on cholinergic function and weight gain. Neuroreport (1992) 1.00
Nerve growth factor and Alzheimer's disease. Ann Neurol (1986) 1.00
Rescue of lesioned septal cholinergic neurons by nerve growth factor: specificity and requirement for chronic treatment. J Neurosci (1988) 0.99
The site of dopamine formation in rat striatum after L-dopa administration. J Pharmacol Exp Ther (1981) 0.99
Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture. J Neurosci Res (1990) 0.99
Localization of nerve growth factor receptors in cholinergic neurons of the human basal forebrain. Neurosci Lett (1986) 0.98
Induction of tyrosine hydroxylase by nerve growth factor and by elevated K+ concentrations in cultures of dissociated sympathetic neurons. J Neurosci (1982) 0.98
The nature of the trophic action of brain-derived neurotrophic factor, des(1-3)-insulin-like growth factor-1, and basic fibroblast growth factor on mesencephalic dopaminergic neurons developing in culture. Neuroscience (1993) 0.98
Circling behavior in rats with partial, unilateral nigro-striatal lesions: effect of amphetamine, apomorphine, and DOPA. Pharmacol Biochem Behav (1980) 0.97
Cerebellar brain-derived neurotrophic factor-TrkB defect associated with impairment of eyeblink conditioning in Stargazer mutant mice. J Neurosci (1998) 0.97
Induction of noncatalytic TrkB neurotrophin receptors during axonal sprouting in the adult hippocampus. J Neurosci (1993) 0.96
Selective failure of brain-derived neurotrophic factor mRNA expression in the cerebellum of stargazer, a mutant mouse with ataxia. J Neurosci (1996) 0.96
The proliferative response to vascular injury is suppressed by angiotensin-converting enzyme inhibition. J Cardiovasc Pharmacol (1990) 0.96
Ligand-induced down-regulation of Trk messenger RNA, protein and tyrosine phosphorylation in rat cortical neurons. Neuroscience (1997) 0.95
BDNF mRNA expression in the developing rat brain following kainic acid-induced seizure activity. Neuron (1992) 0.95
Cardiovascular effects of the new angiotensin-converting-enzyme inhibitor, cilazapril, in anesthetized and conscious dogs. J Cardiovasc Pharmacol (1986) 0.94
OAK knee evaluation. A new way to assess knee ligament injuries. Clin Orthop Relat Res (1988) 0.94
Stimulation of nigrostriatal dopamine neurones by nicotine. Neuropharmacology (1982) 0.94
Growth of dissociated neurons in culture dishes coated with synthetic polymeric amines. Neurosci Lett (1984) 0.93
Elevated mRNA expression of brain-derived neurotrophic factor in retinal ganglion cell layer after optic nerve injury. Invest Ophthalmol Vis Sci (1997) 0.93
Free vascular fibular transfer in congenital pseudoarthrosis of the tibia: results of the EPOS multicenter study. European Paediatric Orthopaedic Society (EPOS). J Pediatr Orthop B (2000) 0.92
Guidance of acetylcholinesterase-containing fibres by target tissue in co-cultured brain slices. Neuroscience (1984) 0.92
Regionally specific and rapid increases in brain-derived neurotrophic factor messenger RNA in the adult rat brain following seizures induced by systemic administration of kainic acid. Neuroscience (1992) 0.92
Rapid phosphorylation of phospholipase C gamma 1 by brain-derived neurotrophic factor and neurotrophin-3 in cultures of embryonic rat cortical neurons. J Neurochem (1993) 0.91
A fluorometric micromethod for the simultaneous determination of serotonin, noradrenaline and dopamine in milligram amounts of brain tissue. Biochem Pharmacol (1974) 0.91
The fibula in congenital pseudoarthrosis of the tibia: the EPOS multicenter study. European Paediatric Orthopaedic Society (EPOS). J Pediatr Orthop B (2000) 0.91
Potential use of nerve growth factor to treat Alzheimer's disease. Neurobiol Aging (1989) 0.91
High-performance size-exclusion chromatography: a buffer for the reliable determination of molecular weights of proteins. Anal Biochem (1982) 0.91
The non-peptidyl fungal metabolite L-783,281 activates TRK neurotrophin receptors. J Neurochem (2001) 0.90
Suppression of L-dopa-induced circling in rats with nigral lesions by blockade of central dopa-decarboxylase: implications for mechanism of action of L-dopa in parkinsonism. Neurology (1984) 0.90
Arthrogrypotic joint contracture at the knee and the foot: correction with a circular frame. J Pediatr Orthop B (1997) 0.90
Decreases of vascular hypertrophy in four different types of arteries in spontaneously hypertensive rats. Am J Med (1989) 0.89
Comparison of nerve growth factor's effects on development of septum, striatum, and nucleus basalis cholinergic neurons in vitro. J Neurosci Res (1989) 0.88
Analysis of the neurotrophic effects of GPI-1046 on neuron survival and regeneration in culture and in vivo. Neuroscience (1999) 0.88
Trophic actions of transforming growth factor alpha on mesencephalic dopaminergic neurons developing in culture. Neuroscience (1993) 0.88
Neurotrophin-3 reverses experimental cisplatin-induced peripheral sensory neuropathy. Ann Neurol (1995) 0.88
Partial lesions of the nigrostriatal pathway in the rat. Acceleration of transmitter synthesis and release of surviving dopaminergic neurones by drugs. Neuropharmacology (1985) 0.87
[Open laser surgery on the locomotor apparatus]. Orthopade (1996) 0.87
[Treatment of congenital scoliosis with the vertical expandable prosthetic titanium rib implant]. Orthopade (2004) 0.87
Biological and immunological properties of the nerve growth factor from bovine seminal plasma: comparison with the properties of mouse nerve growth factor. Neuroscience (1983) 0.87
Paraquat and Parkinson's disease. Neurology (1987) 0.87
Cholinergic regulation of hippocampal brain-derived neurotrophic factor mRNA expression: evidence from lesion and chronic cholinergic drug treatment studies. Neuroscience (1993) 0.86
Chronoamperometry in vivo: does it interfere with spontaneous neuronal activity in the brain? J Neurosci Methods (1983) 0.86
Combined cuboid/cuneiform osteotomy for correction of residual adductus deformity in idiopathic and secondary club feet. J Bone Joint Surg Br (2000) 0.85
Functional results at the end of skeletal growth in 30 patients affected by congenital pseudoarthrosis of the tibia. J Pediatr Orthop B (2000) 0.85
Stimulation of GABAergic neuron differentiation by NT-4/5 in cultures of rat cerebral cortex. Brain Res Dev Brain Res (1994) 0.85
BDNF and trkB mRNA expression in the hippocampal formation of aging rats. Neurobiol Aging (1993) 0.85
Pharmacological profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A. J Pharmacol Exp Ther (1989) 0.85
BDNF protection of basal forebrain cholinergic neurons after axotomy: complete protection of p75NGFR-positive cells. Neuroreport (1993) 0.85
Tyrosine administration increases striatal dopamine release in rats with partial nigrostriatal lesions. Proc Natl Acad Sci U S A (1980) 0.84
K-252b selectively potentiates cellular actions and trk tyrosine phosphorylation mediated by neurotrophin-3. J Neurochem (1992) 0.84
Cilazapril prevents the development of cardiac hypertrophy and the decrease of coronary vascular reserve in spontaneously hypertensive rats. J Cardiovasc Pharmacol (1988) 0.84
[Osteotomies of the mid- and back-foot in recurrent club foot]. Orthopade (1999) 0.83
Do malignant bone tumors of the foot have a different biological behavior than sarcomas at other skeletal sites? Sarcoma (2013) 0.83
Neurotrophin-4/5 promotes survival and differentiation of rat striatal neurons developing in culture. Eur J Neurosci (1994) 0.83
Distribution of [125I]nerve growth factor in the rat brain following a single intraventricular injection: correlation with the topographical distribution of trkA messenger RNA-expressing cells. Neuroscience (1993) 0.83
Immunohistochemical visualization of brain-derived neurotrophic factor in the rat brain. Eur J Neurosci (1995) 0.83
[Fractures of the lateral humeral condyle in children and adolescents (author's transl)]. Orthopade (1981) 0.83
Cholinergic denervation of the rat hippocampus by fimbrial transection leads to a transient accumulation of nerve growth factor (NGF) without change in mRNANGF content. Neurosci Lett (1986) 0.83
Effects of chronic ACE inhibition on cardiac hypertrophy and coronary vascular reserve in spontaneously hypertensive rats with developed hypertension. J Hypertens (1989) 0.83
Response of embryonic rat hippocampal neurons in culture to neurotrophin-3, brain-derived neurotrophic factor and basic fibroblast growth factor. Neuroscience (1993) 0.82
Neurotrophin-induced trk receptor phosphorylation and cholinergic neuron response in primary cultures of embryonic rat brain neurons. Neuroreport (1992) 0.82
Management of slipped capital femoral epiphysis: results of a survey of the members of the European Paediatric Orthopaedic Society. J Child Orthop (2011) 0.81
Trophic actions of IGF-I, IGF-II and insulin on cholinergic and dopaminergic brain neurons. Adv Exp Med Biol (1991) 0.81
Serotonergic neurones are not involved in action of L-dopa in Parkinson's disease. Nature (1980) 0.81
Neurotrophin-4/5 treatment reduces infarct size in rats with middle cerebral artery occlusion. Neurochem Res (1996) 0.81